Palisade Bio (PALI) Return on Capital Employed (2011 - 2026)

Palisade Bio (PALI) has 16 years of Return on Capital Employed data on file, last reported at 20.66% in Q1 2026.

• On a quarterly basis, Return on Capital Employed rose 17904.0% year-over-year to 20.66% in Q1 2026; TTM through Mar 2026 was 20.66%, a 17904.0% increase from a year earlier, with the FY2025 full-year figure at 26.56%, up 13442.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 20.66%, up from 27.35% in the prior quarter.
• Over the last five years, Return on Capital Employed for PALI reached as high as 20.66% in Q1 2026 and fell as low as 511.14% in Q1 2022.
• Historically, Return on Capital Employed has averaged 182.4% across 5 years, with a median of 149.27% in 2024.
• Across the five-year window, Return on Capital Employed slumped 33230 bps in 2022 and jumped 40998 bps in 2023, its largest moves.
• Year by year, Return on Capital Employed stood at 120.91% in 2022, then rose by 17 bps to 100.74% in 2023, then slumped by 115 bps to 216.23% in 2024, then surged by 87 bps to 27.35% in 2025, then climbed by 24 bps to 20.66% in 2026.
• Per Business Quant data, the three most recent Return on Capital Employed figures were 20.66% in Q1 2026, 27.35% in Q4 2025, and 342.82% in Q3 2025.